Skip to main content
NGNE logo

NGNE · Neurogene Inc.

$37.34 +0.03 (+0.08%) At close · Jul 20
Market Cap
$590.04M
Shares
15.80M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Rachel McMinn $3,209,553
Christine Mikail $2,754,458
Julie Jordan $1,472,307
Fiscal 2024
Executive Total
Rachel McMinn $3,464,815
Christine Mikail $3,362,174
Julie Jordan $2,460,036
Fiscal 2023
Executive Total
Donna Cochener $1,827,432
Sean Smith $1,809,783
Christine Mikail $1,132,484
Rachel McMinn $1,080,629
Stuart Cobb $784,324
Jonathan G. Drachman $549,983
Fiscal 2022
Executive Total
Donna Cochener $993,899
Jonathan G. Drachman $902,179
Rachel McMinn $656,545
Christine Mikail $611,714
Stuart Cobb $458,987
Fiscal 2019
Executive Total
Jonathan G. Drachman $3,823,038
David J. Main $1,963,928
Kamran Alam $1,199,997
Fiscal 2018
Executive Total
David J. Main $4,226,286
Kamran Alam $1,755,527
Fiscal 2017
Executive Total
David J. Main $3,040,314
Kamran Alam $1,430,509
Key facts CIK 1404644 CUSIP 64135M105 13F (30d) 5 filings 5 filers Visit website Investor relations